Park Ha Biological Technology Co., Ltd. Announces Nasdaq Ticker Symbol Change to BYAH
Park Ha Biological Technology (NASDAQ: PHH) will change its Nasdaq ticker symbol to BYAH, effective Tuesday, October 28, 2025. Trading of the Company’s ordinary shares will move from the symbol PHH to BYAH on that date. The Company said the change aims to avoid confusion with a delisted issuer that previously used PHH and to strengthen long-term brand value. No action is required by existing shareholders. The Company will remain listed on Nasdaq and the CUSIP will remain unchanged. The announcement contains standard forward-looking statement disclaimers about risks and uncertainties.
Park Ha Biological Technology (NASDAQ: PHH) cambierà il proprio ticker Nasdaq in BYAH, con effetto martedì 28 ottobre 2025. La negoziazione delle azioni ordinarie della società passerà dal simbolo PHH a BYAH in tale data. L'azienda ha detto che la modifica mira a evitare confusioni con un emittente delistato che precedentemente utilizzava PHH e a rafforzare il valore del marchio a lungo termine. Nessuna azione è richiesta dagli azionisti esistenti. L'azienda rimarrà quotata su Nasdaq e lo CUSIP rimarrà invariato. L'annuncio contiene disclaimer standard sulle dichiarazioni previsionali riguardo a rischi e incertezze.
Park Ha Biological Technology (NASDAQ: PHH) cambiará su símbolo en Nasdaq a BYAH, con efecto a partir del martes 28 de octubre de 2025. La negociación de las acciones ordinarias de la compañía pasará del símbolo PHH a BYAH en esa fecha. La empresa indicó que el cambio busca evitar confusiones con un emisor eliminado que previamente utilizaba PHH y fortalecer el valor de la marca a largo plazo. No se requiere ninguna acción por parte de los accionistas existentes. La empresa seguirá cotizando en Nasdaq y el CUSIP permanecerá sin cambios. El anuncio contiene advertencias estándar sobre declaraciones prospectivas acerca de riesgos e incertidumbres.
Park Ha Biological Technology (NASDAQ: PHH)는 BYAH로 나스닥 표시기호를 변경할 예정이며, 유효 시각은 2025년 10월 28일 화요일입니다. 해당일에 회사의 보통주 거래는 PHH에서 BYAH로 이동합니다. 회사는 이 변경이 PHH를 이전에 사용하던 상장폐지된 발행자와의 혼동을 피하고 장기 브랜드 가치를 강화하기 위한 것이라고 밝혔습니다. 기존 주주가 별도의 조치를 할 필요는 없습니다. 회사는 나스닥에 계속 상장되며 CUSIP도 변경되지 않습니다. 발표에는 위험과 불확실성에 대한 표준 미래지향적 진술 면책 조항이 포함되어 있습니다.
Park Ha Biological Technology (NASDAQ: PHH) va changer son symbole Nasdaq en BYAH, avec effet mardi 28 octobre 2025. La négociation des actions ordinaires de la société se déplacera du symbole PHH à BYAH à cette date. La société a déclaré que ce changement vise à éviter toute confusion avec un émetteur radié qui utilisait auparavant PHH et à renforcer la valeur de la marque à long terme. Aucune action n'est requise de la part des actionnaires existants. La société restera cotée sur Nasdaq et le CUSIP restera inchangé. L'annonce contient les mentions standard de prévues sur les déclarations prospectives concernant les risques et les incertitudes.
Park Ha Biological Technology (NASDAQ: PHH) wird sein Nasdaq-Tickersymbol auf BYAH ändern, mit Wirkung ab Dienstag, dem 28. Oktober 2025. Der Handel der Stammaktien des Unternehmens wird an diesem Datum vom Symbol PHH auf BYAH umgestellt. Das Unternehmen sagte, der Wechsel ziele darauf ab, Verwechselungen mit einem delisteten Emittenten zu vermeiden, der zuvor PHH verwendet hatte, und den langfristigen Markenwert zu stärken. Von bestehenden Aktionären ist kein Handeln erforderlich. Das Unternehmen wird weiterhin an der Nasdaq gelistet bleiben und die CUSIP bleibt unverändert. Die Ankündigung enthält standardmäßige Haftungsausschlüsse zu zukunftsgerichteten Aussagen über Risiken und Ungewissheiten.
Park Ha Biological Technology (NASDAQ: PHH) ستغير رمزها السوقي في ناسداك إلى BYAH، اعتباراً من الثلاثاء 28 أكتوبر 2025. ستنتقل تداولات أسهم الشركة العادية من الرمز PHH إلى BYAH في ذلك التاريخ. قالت الشركة إن التغيير يهدف إلى تجنب الالتباس مع جهة مُدرَجة سابقة استخدمت PHH سابقاً ولتعزيز قيمة العلامة التجارية على المدى الطويل. لا يلزم اتخاذ أي إجراء من قبل المساهمين الحاليين. ستبقى الشركة مدرجة في ناسداك وسيظل CUSIP دون تغيير. يحتوي الإعلان على إخلاءات مسؤوليّة معيارية حول توقعات مستقبلية تتعلق بالمخاطر وعدم اليقين.
- None.
- None.
Wuxi, China, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH; the “Company” or “PHH”) announced that the Company will be changing its ticker symbol from “PHH” to “BYAH”. Effective on Tuesday October 28, 2025, the Company’s ordinary shares will trade on Nasdaq under the new symbol “BYAH”.
“To prevent potential confusion with a delisted company that used the same symbol, we will officially change the ticker symbol,” CEO of the Company, Xiaoqiu Zhang commented. The change of the Company’s ticker symbol to ‘BYAH’ will have a positive impact on building the Company’s long-term brand influence and enhancing our brand value.”
No action is required by existing shareholders with respect to the ticker symbol change. The Company’s ordinary shares will continue to be listed on Nasdaq and the CUSIP will remain unchanged.
Forward-Looking Statements
All statements other than statements of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial projections. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the SEC.
About Park Ha Biological Technology Co., Ltd.
Established in 2016, Park Ha Biological Technology Co., Ltd. is primarily engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions under the proprietary brand “Park Ha”, with a commitment to providing cost-effective solutions to skin problems and improving the confidence of women in need of skin treatment. As of April 30, 2025, the Company has three directly operated stores and 39 franchisees, of which 38 and one operate under the store name “Park Ha” and “Geni” respectively, in China. As part of its value-added service for the products, the Company offers “light beauty experience”, a quick complimentary after-sales beauty service performed in the directly-operated stores and franchise stores. For more information, please visit the Company’s website: http://ir.parkha.cn/.
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions in this prospectus. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.
For more information, please contact:
Olivia Li
Email: ir_parkha@163.com
FAQ
When will Park Ha Biological Technology change its Nasdaq ticker from PHH to BYAH?
Do shareholders need to take any action for the PHH to BYAH ticker change?
Will Park Ha Biological Technology shares stay listed on Nasdaq after the symbol change?
Will the CUSIP for Park Ha Biological Technology change when the ticker becomes BYAH?
Why is Park Ha Biological Technology changing its ticker symbol from PHH to BYAH?
Could the PHH to BYAH announcement affect Park Ha Biological Technology financial guidance or filings?
